Comment by
MoneyMKR72 on Sep 30, 2021 6:41am
It may take another quarter to prove testing is going nowhere but this thing is primed for take off even without coming AI revenue. Don't get left behind!! GLTA
Comment by
MoneyMKR72 on Sep 30, 2021 8:59am
I think you misunderstood what I was attempting to say. I agree that testing will be here for the foreseeable future.
Comment by
Leonovus2017 on Sep 30, 2021 12:57pm
I have DM pinned for 50c the way they do business and $2 if they get hype or when they get major investors/good marketing... like wallstreet estimate, its a pure guess especially when we elapsed a full quarter since the last quarterly results
Comment by
nedstar71 on Sep 30, 2021 1:00pm
Simply Wall St is a complete joke. While I think DE is undervalued, anyone putting any stock in anything that website says is kidding themselves.
Comment by
nedstar71 on Sep 30, 2021 1:07pm
And if you doubt me google ANY stock you can think of, the more obscure the better and then select the news tab on google. Most of the entries will be meaningless fill in the blank computer generated garbage created by Simply Wall St.
Comment by
Oden6570 on Sep 30, 2021 1:26pm
I can not vouch for accuracy or rep however they have been around for some time. How accurate is the fair value ???? I do know that the current sp is way undervalued, And I see no other documentation or fair value from anywhere else !
Comment by
Investor10X on Sep 30, 2021 3:07pm
I believe Medi-Call will be the game changer. The revenues from Medi-Call will probably replace the revenues from covid eventually. However, in the meantime there will be an overlap and the company will benefit from both.
Comment by
astutein on Sep 30, 2021 3:31pm
With 355 million shares o/s at $ 5.20 would give market ca of 1.846 billion.
Comment by
SeniorC on Sep 30, 2021 4:44pm
Not Bad! Compacting with Price to Sales ratio of Palantir today, DM (fully diluted at 425M shares) would need 47M$ AI recurring revenues per year to get at 5,20$. With the same ratios only 21M$ per year. So with 75M$ revenues in rapid testing per year end (still no impact on the share price but, the insurance policy... it's all reachable!!! Go DM Go!!!
Comment by
SeniorC on Sep 30, 2021 4:46pm
I meant: with the same ratio only 21M$ per year worth of AI contracts for a 2$ share price... really reachable!!!
Comment by
shaker13 on Sep 30, 2021 9:56pm
HLTH has zero AI or Cyber and yields a MCAP of $1.7 Billion Just saying
Comment by
shaker13 on Sep 30, 2021 9:58pm
https://stockhouse.com/companies/quote?symbol=hlth
Comment by
astutein on Jun 16, 2022 10:10pm
investor10x--Recall your post.
Comment by
Yeehaw1 on Jun 16, 2022 10:21pm
investor10X - tomorrow buy in 10c